Calithera Biosciences, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Calithera Biosciences, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q4 2022.
  • Calithera Biosciences, Inc. Operating Lease, Payments for the quarter ending December 31, 2022 was $300K, a 200% increase year-over-year.
  • Calithera Biosciences, Inc. Operating Lease, Payments for the twelve months ending December 31, 2022 was $1.5M, unchanged year-over-year.
  • Calithera Biosciences, Inc. annual Operating Lease, Payments for 2022 was $1.5M, unchanged from 2021.
  • Calithera Biosciences, Inc. annual Operating Lease, Payments for 2021 was $1.5M, a 28.6% decline from 2020.
  • Calithera Biosciences, Inc. annual Operating Lease, Payments for 2020 was $2.1M, a 8.7% decline from 2019.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $1.5M $300K +$200K +200% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 $1.3M $400K $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.3M $400K $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-16
Q1 2022 $1.3M $400K -$200K -33.3% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $1.5M $100K -$400K -80% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $1.9M $400K $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $1.9M $400K -$200K -33.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-16
Q1 2021 $2.1M $600K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $2.1M $500K $0 0% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-31
Q3 2020 $2.1M $400K -$200K -33.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $2.3M $600K $0 0% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $2.3M $600K $0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $2.3M $500K Oct 1, 2019 Dec 31, 2019 10-K 2022-03-31
Q3 2019 $600K Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $600K Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $600K Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.